Cellosaurus HyCyte L-02 stable cell line for hPCSK9 overexpression (CVCL_F4RI)
| Cell line name | HyCyte L-02 stable cell line for hPCSK9 overexpression |
|---|---|
| Synonyms | L-02 stable cell line for hPCSK9 overexpression |
| Accession | CVCL_F4RI |
| Resource Identification Initiative | To cite this cell line use: HyCyte L-02 stable cell line for hPCSK9 overexpression (RRID:CVCL_F4RI) |
| Comments | Population: African American. Characteristics: Transfected with pPB[Exp]-Neo-CMV>hPCSK9[NM_174936.4](ns):3xGGGGS:EGFP:IRES:mCherry. Doubling time: 24-36 hours (Hysigen=CGSC-M32581). Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; EGFP. Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZERB6; mCherry. Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20001; PCSK9. Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. |
| Disease | Human papillomavirus-related endocervical adenocarcinoma (NCIt: C27677) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_6926 (L-02) |
| Sex of cell | Female |
| Age at sampling | 30Y6M |
| Category | Cancer cell line |
| Cross-references | |
| Cell line collections (Providers) | Hysigen; CGSC-M32581 |
| Entry history | |
| Entry creation | 25-Jun-2026 |
| Last entry update | 25-Jun-2026 |
| Version number | 1 |